US FDA Looks To Resume Unannounced Inspections In India And China
After lapsing due to COVID-19, an unannounced foreign inspection pilot program is on track to resume in 2022, “despite challenges and constraints of travel.”
You may also be interested in...
HHS agencies look to build on COVID-19 experience by developing quicker public/private responses to pandemics and supply chain threats.
The House Appropriations Committee also does not want the agency to become too dependent on alternative inspection tools.
Agency inspectors worked in the country for about a month before the coronavirus infection surge forced another halt.